Page 23 - Nari News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nari Today - Breaking & Trending Today

Inari Medical, Inc. (NASDAQ:NARI) Sees Large Increase in Short Interest

Inari Medical, Inc. (NASDAQ:NARI – Get Rating) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 2,190,000 shares, a growth of 25.1% from the February 28th total of 1,750,000 shares. Approximately 5.0% of the company’s stock are short sold. Based on an average […] ....

United States , William Hoffman , Lindbrook Capital , Morgan Stanley , Carroll Financial Associates Inc , Inari Medical Inc , Zacks Investment Research , Nisa Investment Advisors , Canaccord Genuity Group , Cm Bidwell Associates Ltd , Central Bank Trust Co , Inari Medical , Get Rating , Investment Research , Director Donald , Financial Associates , Investment Advisors , Nasdaq Nari ,

Inari Medical (NASDAQ:NARI) Receives New Coverage from Analysts at Bank of America

Bank of America began coverage on shares of Inari Medical (NASDAQ:NARI – Get Rating) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set a “buy” rating on the stock. NARI has been the topic of a number of other reports. Canaccord Genuity Group reduced their target price on shares […] ....

United States , William Hoffman , Asset Management North America Corp , Inari Medical Inc , Zacks Investment Research , Norges Bank , Blackrock Inc , Weiss Multi Strategy Advisers , Inari Medical Company Profile Get Rating , Canaccord Genuity Group , Inari Medical , Get Rating , Genuity Group , Director Donald , Multi Strategy Advisers , Management North America , Medical Company Profile , Nasdaq Nari , Initiated Coverage , Bank Of America Co ,

Canaccord Genuity Group Cuts Inari Medical (NASDAQ:NARI) Price Target to $96.00

Inari Medical (NASDAQ:NARI – Get Rating) had its target price cut by Canaccord Genuity Group from $102.00 to $96.00 in a research note published on Monday morning, The Fly reports. Other equities research analysts also recently issued research reports about the company. Canaccord Genuity Group decreased their price target on Inari Medical from $102.00 to […] ....

United States , Thomson Reuter , William Hoffman , Andrew Hykes , Morgan Stanley , Goldman Sachs Group Inc , Inari Medical Inc , Zacks Investment Research , Inari Medical Company Profile Get Rating , Charles Schwab Investment Management Inc , Canaccord Genuity Group , Royal Bank , Inari Medical , Get Rating , Genuity Group , Sachs Group , Schwab Investment Management , Medical Company Profile , Nasdaq Nari , Lower Price Target , Canaccord Genuity Group Inc ,

Insider Selling: Inari Medical, Inc. (NASDAQ:NARI) CEO Sells 60,000 Shares of Stock

Inari Medical, Inc. (NASDAQ:NARI – Get Rating) CEO William Hoffman sold 60,000 shares of the stock in a transaction on Monday, March 7th. The shares were sold at an average price of $95.48, for a total transaction of $5,728,800.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through […] ....

New Zealand General , New Zealand , United States , Thomson Reuter , William Hoffman , Morgan Stanley , Inari Medical Inc , Zacks Investment Research , Wellington Management Group , Blackrock Inc , Inari Medical Company Profile Get Rating , Capital International Investors , Macquarie Group Ltd , Inari Medical , Get Rating , International Investors , Management Group , Investment Research , Medical Company Profile , Nasdaq Nari , Insider Trading , Nsider Trades ,